Navigation Links
Apex BioStrategists Advises On Flow Cytometry Sale To Coulter
Date:5/22/2012

MIAMI, May 22, 2012 /PRNewswire-iReach/ -- APEX BIOSTRATEGISTS, A FULL SERVICE ADVISORY FIRM, LED THE TEAM ADVISING THE SELLERS IN THE RECENT ASSET SALE BY NPE SYSTEMS, INC. AND BLUE OCEAN BIOMEDICAL, LLC, BOTH OF PEMBROKE PINES, FLORIDA, TO BECKMAN COULTER. NPE AND BLUE OCEAN WERE TECHNOLOGY LEADERS IN THE FIELD OF FLOW CYTOMETRY WHICH PROVIDES DIAGNOSTIC BLOOD AND TISSUE TESTING FOR PATIENT MONITORING AND FOR DRUG RESEARCH. BECKMAN COULTER IS A MARKET LEADER IN THE SALE OF FLOW CYTOMETRY SYSTEMS TO HOSPITALS AND TESTING LABS THROUGHOUT THE WORLD.

"WE HAVE BEEN ADVISING NPE AND BLUE OCEAN FOR SEVERAL YEARS AS THEY DEVELOPED CUTTING EDGE TECHNOLOGIES AND LICENSED THEM TO MAJOR COMPANIES INCLUDING COULTER AND SONY IN THE PAST.", SAID MARTIN DOYLE, PRINCIPAL OF APEX. "IT IS REALLY GRATIFYING WHEN WE SEE A CLIENT GROW FROM LITERALLY A GARAGE TO A WORLD CLASS COMPANY THAT CAN OFFER THEIR TECHNOLOGY TO A QUALITY COMPANY LIKE BECKMAN COULTER. WE ARE VERY PLEASE TO HAVE HAD THE OPPORTUNITY TO WORK WITH THE OWNERS AND EMPLOYEES TO GUIDE THEIR GROWTH AND HELP THEM NAVIGATE TO THIS VERY SUCCESSFUL CONCLUSION", CONTINUED DOYLE. "WE ARE HAPPY TO SEE THEIR HARD WORK AND SACRIFICE PAY OFF. THIS IS THE CLASSIC ENTREPRENEURIAL SUCCESS STORY, AND ONE WE SEE WITH OUR CLIENTS AROUND THE WORLD AS MORE ESTABLISHED COMPANIES LOOK TO INVENTIVE SHOPS LIKE NPE AND BLUE OCEAN FOR INNOVATION AND NEW PRODUCTS."

NPE AND BLUE OCEAN DEVELOPED AN INTEGRATED BLOOD TESTING SYSTEM THAT WILL BE SMALLER, LESS COSTLY AND MUCH MORE AUTOMATED THAN THOSE CURRENTLY FOUND IN HOSPITAL TEST FACILITIES OR OUTSIDE REFERENCE LABS. THESE NEW SYSTEMS REDUCE THE LABOR FACTOR, INCREASE THROUGHPUT AND GENERALLY MEET THE NEEDS OF THE CLINICAL AND RESEARCH INDUSTRIES, ACCORDING TO DOYLE. FLOW CYTOMETRY USED TO TEST FOR DISEASE, MONITOR MEDICATION LEVELS IN BLOOD AND CHARACTERIZE TISSUE BIOPSIES. BY MAKING THE TESTING SYSTEM SMALLER AND EASIER TO USE, NPE AND BLUE OCEAN HAVE ENABLED BOTH BIG MEDICAL CENTERS AND PHYSICIANS OFFICES TO OBTAIN TEST RESULTS MORE EFFICIENTLY AND IN A SHORT TIME. 

ABOUT APEX BIOSTRATEGISTS: APEX IS AN ESTABLISHED ADVISORY FIRM SPECIALIZING IN ASSISTING SMALL COMPANIES, THEIR MANAGEMENT AND INVESTORS  TO REACH THEIR GOALS. THE APEX TEAM CONSISTS OF EXPERIENCED BUSINESS EXECUTIVES, SUCCESSFUL ENTREPRENEURS AND PROFESSIONALS WHO HAVE YEARS OF PRACTICAL AND PROFESSIONAL EXPERIENCE AND EXTENSIVE NETWORKS AROUND THE WORLD TO BENEFIT THEIR CLIENTS.  AT APEX, WE SOLVE PROBLEMS AND HELP OUR CLIENTS ACHIEVE THEIR GOALS INCLUDING VALUE OPTIMIZATION, SUCCESSFUL INVESTMENT EXIT, TECHNOLOGY LICENSES, STRATEGIC PLANS AND SITUATIONAL ASSESSMENT.

FOR MORE INFORMATION, PLEASE SEE WWW.APEXBIOSTRAT.COM OR EMAIL:INFO@APEXBIOSTRAT.COM

CONTACT:
MARTIN DOYLE
305-206-1513
MDOYLE@APEXBIOSTRAT.COM

Media Contact:

Martin Doyle Apex BioStrategists, 305-206-1513, med9344@aol.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Apex BioStrategists
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
2. Glass Lewis Advises Taro Shareholders to Hold Taros Board Accountable for Its Failures
3. E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis
4. BB&T Advises Dr. Comfort on Its Sale to DJO Global in Transaction Valued at $254.6 Million
5. Carl Marks Advises Scovill Fasteners in Sale of Company
6. Equipment Leasing Offers Attractive Options for Medical Practices, but Be Aware of Risks, LeClairRyan Attorney Advises
7. Trust Your Derm: The JUVA Skin & Laser Center Advises Patients To Seek Board Certified Dermatologists and AAAHC Accredited Facilities For Safe Cosmetic Procedures
8. ECRI Institute Advises Hospitals on How to Avoid the Pitfalls of Medical Device Connectivity
9. IOD Incorporated Advises Healthcare Providers to Stay the Course in Preparation for ICD-10
10. Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
11. Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
(Date:2/21/2017)... , Feb. 21, 2017 Research and Markets ... Devices - Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a ...
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Uterine cancer Drugs Price Analysis and Strategies ... cancer market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Uterine cancer ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... February 21, 2017 , ... ... Philpart, senior director at PolicyLink, will be the keynote speaker at its second ... and Men of Color Framework, which develops comprehensive strategies to create and expand ...
(Date:2/21/2017)... ... February 21, 2017 , ... Support of value-based care ... the secure exchange of data across industry solutions, Fogo Data Centers announces the launch ... community. A healthy community is one in which all systems work well, work ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS is ... connected care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, and ... providers have no Health Information Exchange outside of faxing. Medal’s innovative technology “meets ...
(Date:2/20/2017)... ... February 20, 2017 , ... A new digital ... are called back for additional examinations without sacrificing cancer detection, according to a ... the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for use ...
(Date:2/20/2017)... ... February 20, 2017 , ... Scrubbing in for his first ... Dr. Christopher Pezzi remembers the excitement of the surgeon training him. , “He was ... to do this? Don’t tell anyone, but I would do it for free,’” Dr. ...
Breaking Medicine News(10 mins):